Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (11-20 of 228) with videos related to

Pageof 23
Sort By:
The Lancet. Oncology|November 6, 2012
Primary systemic treatment of breast-cancer brain metastasesRupert Bartsch, Matthias Preusser
Memo|January 1, 2019
ASCO 2018: highlights in HER2-positive metastatic breast cancerRupert Bartsch, Elisabeth Bergen
The Lancet. Oncology|June 19, 2012
Bisphosphonates in early breast cancerPeter Dubsky, Rupert Bartsch
Neuro-Oncology|October 3, 2024
Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases?Rupert Bartsch, Matthias Preusser
Breast Care (Basel, Switzerland)|September 18, 2010
The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future ToolsRupert Bartsch, Guenther G Steger
Memo|April 3, 2018
My burning issues in the neoadjuvant treatment for breast cancerElisabeth S Bergen, Rupert Bartsch
Therapeutic Advances in Medical Oncology|September 30, 2011
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinionGuenther G Steger, Rupert Bartsch
ESMO Open|December 1, 2016
I-SPY 2: optimising cancer drug development in the 21st centuryRupert Bartsch, Evandro de Azambuja
Expert Opinion on Biological Therapy|August 6, 2009
Role of denosumab in breast cancerRupert Bartsch, Guenther G Steger
Breast Care (Basel, Switzerland)|March 16, 2012
Trends and Novel Approaches in Neoadjuvant Treatment of Breast CancerGuenther G Steger, Rupert Bartsch
Pageof 23

Showing results (11-20 of 228) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|November 6, 2012
Primary systemic treatment of breast-cancer brain metastasesRupert Bartsch, Matthias Preusser
Memo|January 1, 2019
ASCO 2018: highlights in HER2-positive metastatic breast cancerRupert Bartsch, Elisabeth Bergen
The Lancet. Oncology|June 19, 2012
Bisphosphonates in early breast cancerPeter Dubsky, Rupert Bartsch
Neuro-Oncology|October 3, 2024
Trastuzumab deruxtecan: Defining a novel systemic treatment standard for HER2-positive breast cancer brain metastases?Rupert Bartsch, Matthias Preusser
Breast Care (Basel, Switzerland)|September 18, 2010
The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future ToolsRupert Bartsch, Guenther G Steger
Memo|April 3, 2018
My burning issues in the neoadjuvant treatment for breast cancerElisabeth S Bergen, Rupert Bartsch
Therapeutic Advances in Medical Oncology|September 30, 2011
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinionGuenther G Steger, Rupert Bartsch
ESMO Open|December 1, 2016
I-SPY 2: optimising cancer drug development in the 21st centuryRupert Bartsch, Evandro de Azambuja
Expert Opinion on Biological Therapy|August 6, 2009
Role of denosumab in breast cancerRupert Bartsch, Guenther G Steger
Breast Care (Basel, Switzerland)|March 16, 2012
Trends and Novel Approaches in Neoadjuvant Treatment of Breast CancerGuenther G Steger, Rupert Bartsch
Pageof 23